Cargando…

Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor

BACKGROUND: Axillary lymph nodes (ALN) are the most commonly involved site of disease in breast cancer that has spread outside the primary lesion. Although sentinel node biopsy is a reliable way to manage ALN, there are still no good methods of predicting ALN status before surgery. Since morbidity i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Jia-Long, Tseng, Hsin-Shun, Yang, Li-Heng, Wu, Hwa-Koon, Kuo, Shou-Jen, Chen, Shou-Tung, Chen, Dar-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989944/
https://www.ncbi.nlm.nih.gov/pubmed/24714517
http://dx.doi.org/10.12659/MSM.890345
_version_ 1782312207395061760
author Wu, Jia-Long
Tseng, Hsin-Shun
Yang, Li-Heng
Wu, Hwa-Koon
Kuo, Shou-Jen
Chen, Shou-Tung
Chen, Dar-Ren
author_facet Wu, Jia-Long
Tseng, Hsin-Shun
Yang, Li-Heng
Wu, Hwa-Koon
Kuo, Shou-Jen
Chen, Shou-Tung
Chen, Dar-Ren
author_sort Wu, Jia-Long
collection PubMed
description BACKGROUND: Axillary lymph nodes (ALN) are the most commonly involved site of disease in breast cancer that has spread outside the primary lesion. Although sentinel node biopsy is a reliable way to manage ALN, there are still no good methods of predicting ALN status before surgery. Since morbidity in breast cancer surgery is predominantly related to ALN dissection, predictive models for lymph node involvement may provide a way to alert the surgeon in subgroups of patients. MATERIAL/METHODS: A total of 1325 invasive breast cancer patients were analyzed using tumor biological parameters that included age, tumor size, grade, estrogen receptor, progesterone receptor, lymphovascular invasion, and HER2, to test their ability to predict ALN involvement. A support vector machine (SVM) was used as a classification model. The SVM is a machine-learning system developed using statistical learning theories to classify data points into 2 classes. Notably, SVM models have been applied in bioinformatics. RESULTS: The SVM model correctly predicted ALN metastases in 74.7% of patients using tumor biological parameters. The predictive ability of luminal A, luminal B, triple negative, and HER2 subtypes using subgroup analysis showed no difference, and this predictive performance was inferior, with only 60% accuracy. CONCLUSIONS: With an SVM model based on clinical pathologic parameters obtained in the primary tumor, it is possible to predict ALN status in order to alert the surgeon about breast cancer counseling and in decision-making for ALN management.
format Online
Article
Text
id pubmed-3989944
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International Scientific Literature, Inc.
record_format MEDLINE/PubMed
spelling pubmed-39899442014-04-17 Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor Wu, Jia-Long Tseng, Hsin-Shun Yang, Li-Heng Wu, Hwa-Koon Kuo, Shou-Jen Chen, Shou-Tung Chen, Dar-Ren Med Sci Monit Clinical Research BACKGROUND: Axillary lymph nodes (ALN) are the most commonly involved site of disease in breast cancer that has spread outside the primary lesion. Although sentinel node biopsy is a reliable way to manage ALN, there are still no good methods of predicting ALN status before surgery. Since morbidity in breast cancer surgery is predominantly related to ALN dissection, predictive models for lymph node involvement may provide a way to alert the surgeon in subgroups of patients. MATERIAL/METHODS: A total of 1325 invasive breast cancer patients were analyzed using tumor biological parameters that included age, tumor size, grade, estrogen receptor, progesterone receptor, lymphovascular invasion, and HER2, to test their ability to predict ALN involvement. A support vector machine (SVM) was used as a classification model. The SVM is a machine-learning system developed using statistical learning theories to classify data points into 2 classes. Notably, SVM models have been applied in bioinformatics. RESULTS: The SVM model correctly predicted ALN metastases in 74.7% of patients using tumor biological parameters. The predictive ability of luminal A, luminal B, triple negative, and HER2 subtypes using subgroup analysis showed no difference, and this predictive performance was inferior, with only 60% accuracy. CONCLUSIONS: With an SVM model based on clinical pathologic parameters obtained in the primary tumor, it is possible to predict ALN status in order to alert the surgeon about breast cancer counseling and in decision-making for ALN management. International Scientific Literature, Inc. 2014-04-08 /pmc/articles/PMC3989944/ /pubmed/24714517 http://dx.doi.org/10.12659/MSM.890345 Text en © Med Sci Monit, 2014 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License
spellingShingle Clinical Research
Wu, Jia-Long
Tseng, Hsin-Shun
Yang, Li-Heng
Wu, Hwa-Koon
Kuo, Shou-Jen
Chen, Shou-Tung
Chen, Dar-Ren
Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor
title Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor
title_full Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor
title_fullStr Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor
title_full_unstemmed Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor
title_short Prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor
title_sort prediction of axillary lymph node metastases in breast cancer patients based on pathologic information of the primary tumor
topic Clinical Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989944/
https://www.ncbi.nlm.nih.gov/pubmed/24714517
http://dx.doi.org/10.12659/MSM.890345
work_keys_str_mv AT wujialong predictionofaxillarylymphnodemetastasesinbreastcancerpatientsbasedonpathologicinformationoftheprimarytumor
AT tsenghsinshun predictionofaxillarylymphnodemetastasesinbreastcancerpatientsbasedonpathologicinformationoftheprimarytumor
AT yangliheng predictionofaxillarylymphnodemetastasesinbreastcancerpatientsbasedonpathologicinformationoftheprimarytumor
AT wuhwakoon predictionofaxillarylymphnodemetastasesinbreastcancerpatientsbasedonpathologicinformationoftheprimarytumor
AT kuoshoujen predictionofaxillarylymphnodemetastasesinbreastcancerpatientsbasedonpathologicinformationoftheprimarytumor
AT chenshoutung predictionofaxillarylymphnodemetastasesinbreastcancerpatientsbasedonpathologicinformationoftheprimarytumor
AT chendarren predictionofaxillarylymphnodemetastasesinbreastcancerpatientsbasedonpathologicinformationoftheprimarytumor